Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HST-NEETs in HIV-infected individuals on ART
NCT03485963Phase 1Completed
- Sponsor
- Catherine Bollard
- Start
- Mar 2019
- Primary completion
- Sep 2021
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of HST-NEETs in human immunodeficiency virus infection (HIV), sponsored by Catherine Bollard. Primary endpoint: Incidence of Product-Emergent Adverse Events. Started Mar 2019; status: completed.
02
Drugs
HST-NEETs
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03485963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03485963.